Randomized controlled trial on occupational graduated compression clinical and cost-effectiveness

被引:0
|
作者
Gianesini, Sergio [1 ,2 ,3 ,7 ]
Vagnoni, Emidia [4 ]
Cavicchi, Caterina [4 ]
Chi, Yung -Wei [5 ]
Pagani, Anselmo [1 ]
Tessari, Mirko [3 ]
Zamboni, Paolo [1 ,3 ]
Menegatti, Erica [6 ]
机构
[1] Univ Ferrara, Dept Translat Med, Ferrara, Italy
[2] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD USA
[3] S Anna Univ Hosp, Mini invas Venous Surg Unit, Ferrara, Italy
[4] Univ Ferrara, Dept Econ & Management, Ferrara, Italy
[5] Univ Calif Davis, Vasc Ctr, Div Cardiovasc Med, Davis, CA USA
[6] Univ Ferrara, Dept Environm Sci & Prevent, Ferrara, Italy
[7] Univ Ferrara, via Porta Mare 11, I-45100 Rovigo, Italy
关键词
Stockings; compression; Occupational medicine; Edema; VARICOSE-VEINS; STANDING POSTURE; LEG SYMPTOMS; WORK; HEALTH; PRODUCTIVITY; VOLUME;
D O I
10.23736/S0392-9590.23.05030-7
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Subjects exposed to occupational standing are at risk of developing chronic venous disease. Graduated compression stockings (GCS) counteract venous hypertension. Aim of the present investigation was to assess GCS clinical and cost effectiveness in prolonged standing up workers. Methods: Randomized controlled trial involving 75 healthy healthcare professionals working in 6 hours standing up shifts without or with GCS (group A and B, respectively). Outcome measures were performed before and after the shift, at baseline (T0), at 1 (T1), 6 (T6) and 12 (T12) months and included lower limb volume, air plethysmography (APG), quality of life, and dedicated cost-effectiveness questionnaires. Results: Seventy-two subjects completed the data collection. Leg volume increased in group A and decreased in B at all assessment points (T0, 1, 6, 12) (P<0.0001). Venous filling index did not change within the 12 months, but, after every shift, its value was lower in B compared to A (P<0.0001). At 12 months, VVSymQ worsened in A and improved in B (P<0.0001) and CIVIQ significantly worsened in A (P<0.0001), while in B it significantly improved (P<0.0001). Perceived disability was higher in A at 12 months (P<0.001) and the cost calculation revealed a saving of 1510 euro per year in B. Conclusions: GCS counteracted occupational oedema and positively influenced venous filling index, while improving vein specific quality of life measurements in addition to cost savings.
引用
收藏
页码:344 / 351
页数:8
相关论文
共 50 条
  • [41] Mid-term effect of customized graduated elastic compression stockings for managing occupational edema: A randomized controlled trial
    Wang, Sheng-Xing
    Yang, Wen-Tao
    Jin, Zhen-Yi
    Wen, Jia-Hao
    Ren, Hua-Liang
    Xiong, Ying
    Tao, Xiao-Ming
    Li, Chun-Min
    VASCULAR MEDICINE, 2025, 30 (01) : 50 - 57
  • [42] Study protocol of the cost-effectiveness comparison of two preventive methods in the incidence of caries A randomized, controlled clinical trial
    Angel Fernandez-Barrera, Miguel
    Lara-Carrillo, Edith
    Jose Scougall-Vilchis, Rogelio
    Pontigo-Loyola, America Patricia
    Avila-Burgos, Leticia
    Fernando Casanova-Rosado, Juan
    Jose Casanova-Rosado, Alejandro
    Minaya-Sanchez, Mirna
    Eduardo Medina-Solis, Carlo
    MEDICINE, 2019, 98 (30) : e16634
  • [43] The Clinical Impact and Cost-Effectiveness of Essential Oils and Aromatherapy for the Treatment of Acne Vulgaris: A Protocol for a Randomized Controlled Trial
    Agnew, Tamara
    Leach, Matthew
    Segal, Leonie
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2014, 20 (05) : 399 - 405
  • [44] Cost-effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trial
    Bekkers, Stijn
    van Ulsen, Kim J.
    Adang, Eddy M. M.
    Scheffer, Arthur R. T.
    van den Hoogen, Frank J. A.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2020, 62 (11): : 1302 - 1308
  • [45] Cost-effectiveness as an outcome in randomized clinical trials
    Hlatky, Mark A.
    Owens, Douglas K.
    Sanders, Gillian D.
    CLINICAL TRIALS, 2006, 3 (06) : 543 - 551
  • [46] Cost-effectiveness of an intervention to reduce fear of cancer recurrence: The ConquerFear randomized controlled trial
    Shih, Sophy Ting-Fang
    Butow, Phyllis
    Bowe, Steven J.
    Thewes, Belinda
    Turner, Jane
    Gilchrist, Jemma
    Mihalopoulos, Cathrine
    PSYCHO-ONCOLOGY, 2019, 28 (05) : 1071 - 1079
  • [47] Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis
    Laheij, RJF
    Severens, JL
    Van de Lisdonk, EH
    Verbeek, ALM
    Jansen, JBM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (12) : 1249 - 1256
  • [48] Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial
    Henderson, Catherine
    Knapp, Martin
    Stirling, Susan
    Shepstone, Lee
    High, Juliet
    Ballard, Clive
    Bentham, Peter
    Burns, Alistair
    Farina, Nicolas
    Fox, Chris
    Fountain, Julia
    Francis, Paul
    Howard, Robert
    Leroi, Iracema
    Livingston, Gill
    Nilforooshan, Ramin
    Nurock, Shirley
    O'Brien, John T.
    Price, Annabel
    Swart, Ann Marie
    Tabet, Naji
    Telling, Tanya
    Thomas, Alan J.
    Banerjee, Sube
    INTERNATIONAL PSYCHOGERIATRICS, 2022, 34 (10) : 905 - 917
  • [49] Cost-Effectiveness of Thrombectomy in Patients With Acute Ischemic Stroke The THRACE Randomized Controlled Trial
    Achit, Hamza
    Soudant, Marc
    Hosseini, Kossar
    Bannay, Aurelie
    Epstein, Jonathan
    Bracard, Serge
    Guillemin, Francis
    STROKE, 2017, 48 (10) : 2843 - 2847
  • [50] Cost-effectiveness of a chronic disease management model for cirrhosis: Analysis of a randomized controlled trial
    Wigg, Alan J.
    Chin, Jong K.
    Muller, Kate R.
    Ramachandran, Jeyamani
    Woodman, Richard J.
    Kaambwa, Billingsley
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (09) : 1634 - 1640